
Novo Nordiskâs Powerful $2.1B Vivtex Partnership: A Game-Changing Push for Next-Generation Oral Obesity Drugs
Novo Nordisk and Vivtex Team Up to Develop Next-Generation Oral Obesity Drugs in a Deal Worth Up to $2.1 BillionNovo Nordisk, the Danish pharmaceutica...















































